A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.

Nam Q BuiJoanna PrzybylSally E TrabuccoGarrett FramptonTrevor HastieMatt van de RijnKristen N Ganjoo

Published in: Clinical sarcoma research (2019)

Our clinico-genomic profiling of STS shows that CDKN2A deletion was the most prevalent DNA copy number aberration and was associated with poor prognosis.

Keyphrases

poor prognosis
copy number
long non coding rna
mitochondrial dna
end stage renal disease
genome wide
ejection fraction
dna methylation
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
cell free
single molecule
patient reported